Primary Responsibilities
- Build, lead, and scale the marketing function; manage budget, resources, vendor/agency relationships, and KPIs tied to demand generation and launch readiness
- Develop and execute integrated brand and launch planning strategies for Lexeo’s cardiac pipeline (initially US-focused and future global expansion)
- Shape and evolve Lexeo’s brand story as a leader in genetic cardiovascular medicine, partner with external communications (media, PR, social, thought leadership, IR)
- Build deep customer segmentation and personas across key stakeholders: opinion leaders, cardiologists, genetic specialists, patient advocacy groups, and other members of multi-disciplinary care teams
- Lead disease awareness and diagnosis-activation initiatives in partnership with Medical and Patient Affairs
- Define evidence needs and value propositions for payer engagement, pricing, and provider strategies
- Contribute to strategic planning and commercial prioritization across the portfolio
- Develop messaging frameworks for HCPs, patients, and payers, emphasizing genetic causes, durability, and impact of therapies.
- Expand Lexeo commercial infrastructure with an eye towards commercial launches, including data and analytics, field reporting, patient support and commercial intelligence
- Serve as the commercial voice on cross-functional teams, ensuring alignment from early stage through launch
- Collaborate with new and growing field teams, including market access, medical affairs, field reimbursement and sales
Required Skills & Qualifications
- Bachelor’s in Life Sciences, Marketing, or Business required; MBA, PharmD, or PhD preferred.
- 10+ years in life sciences marketing or launch planning (rare disease, gene therapy, advanced biologics), with both upstream (strategy, portfolio) and downstream (brand, digital) experience.
- Experience in developing launch readiness for novel therapies (cell/gene therapies, biologics in rare/monogenic disease); experience in specialty/high-science areas is preferred
- Strong scientific acumen; familiarity with AAV platforms, manufacturing, and regulatory pathways.
- Deep competency in digital/omnichannel marketing: CRM, automation, SEO/SEM, analytics, content strategy.
- Strong cross-functional collaboration skills and ability to influence senior leadership
- Ability to translate complex science into compelling commercial narratives
Top Skills
What We Do
LEXEO Therapeutics is a New York City-based, clinical-stage gene therapy company focused on addressing some of the most devastating genetically defined cardiovascular and central nervous system diseases affecting both larger-rare and prevalent patient populations. LEXEO’s foundational science stems from partnerships and exclusive licenses with leading academic laboratories at Weill Cornell Medical College and the University of California, San Diego, two preeminent institutions on the cutting edge of gene therapy research. LEXEO is advancing a deep and diverse pipeline of AAV-based gene therapy candidates in rare cardiovascular diseases, APOE4-associated Alzheimer’s disease, and CLN2 Batten disease, and is led by pioneers and experts with decades of collective experience in genetic medicines, rare disease drug development, manufacturing and commercialization.
For more information, please visit www.lexeotx.com.



.png)





